SEC Form D private-offering filing

Myrtelle Inc.

Name: Myrtelle Inc. - new SEC Form D private-offering filing, New York, NY
Published: 2026-07-02

A new SEC Form D private-offering notice from New York, NY, a $30,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Myrtelle Inc. Verified via SEC Form D

Gene therapy company developing rAAV-based treatments for Canavan disease and other myelin-related neurological disorders.

Filed 2026-07-02Filed to raise $30,000,000First money in 2026-06-22Raised so far $16,700,000HQ (as filed) New York, NYSector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.